Use of Cytochrome P450-Specific Parameters and Human Biomarker Data To Develop a Human Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Dermal Chlorpyrifos Exposure

Use of Cytochrome P450-Specific Parameters and Human Biomarker Data To Develop a Human Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Dermal Chlorpyrifos Exposure

Author(s):

Publication title:

Parameters for pesticide QSAR and PBPK/PD models for human risk assessment

Title of ser.:

ACS symposium series

Ser. no.:

1099

Pub. Year:

2012

Page(from):

309

Page(to):

322

Pages:

14

Pub. info.:

Washington, DC: American Chemical Society

ISSN:

00976156

ISBN:

9780841226456 [0841226458]

Language:

English

Call no.:

A05800/1099

Type:

Conference Proceedings

Details

TDL ID:	ZA00051818
Series ID:	PA00000004
Conf. info. (Name):	the 242nd ACS National Meeting
Conf. info. (Number):	242nd
Conf. info. (Date):	2011.08.28-2011.09.01

Similar Items:

1 Conference Proceedings Prediction of Anticholinesterase Activity and Urinary Metabolites of Isofenphos: Use of a Percutaneous Physiologically Based Pharmacokinetic-Physiologically … Knaak, J. B., Al-Bayati, M. A., Raabe, O. G., Blancato, Jerry N. American Chemical Society	7 Conference Proceedings Synthesis of Grashof Four-Bar Mechanisms Using Particle Swarm Optimization Robin McDougall, Scott Nokleby American Society of Mechanical Engineers
2 Conference Proceedings Use of a Multiple Pathway and Multiroute Physiologically Based Pharmacokinetic Model for Predicting Organophosphorus Pesticide Toxicity Knaak, James B., Al-Bayati, Mohammed A., Raabe, Otto G., Blancato, Jerry N. American Chemical Society	8 Conference Proceedings (596am) Physiologically Based Pharmacokinetic and Pharmacodynamic Approach to Nanoparticle Biodistribution and Tumor Uptake: A Comparison Between Gold … Angel A. Galvis, Ruben D. Vargas, Watson L. Vargas American Institute of Chemical Engineers
3 Conference Proceedings Physiologically Based Pharmacokinetic Models: Examples of Their Use in Exposure and Risk Assessment Blancato, Jerry N., Saleh, Mahmoud A. American Chemical Society	9 Conference Proceedings IMMUNOPHARMACOKINETICS: THE PHARMACOKINETICS AND PHARMACODYNAMICS OF IMMUNOREGULATING DRUGS Benet Z. L., Legler F. U., Tsang Y. S., Frey M. B., Frey J. F. Springer-Verlag
4 Conference Proceedings Dermal Dose-Cholinesterase Response and Percutaneous Absorption Studies with Several Cholinesterase Inhibitors Knaak, James B., Wilson, Barry W. American Chemical Society	10 Conference Proceedings Parameters for Pesticide QSAR and PBPK/PD Models To Inform Human Risk Assessments M. R. Goldsmith, J. C. Johnson, D. T. Chang, R. Tornero-Velez, J. B. Knaak, Curtis C. Dary American Chemical Society
5 Conference Proceedings Use of Spot Urine Sample Results in Physiologically Based Pharmacokinetic Modeling of Absorbed Malathion Doses in Humans Dong, Michael H., Ross, John H., Thongsinthusak, Thomas, Krieger, Robert I. American Chemical Society	11 Conference Proceedings The role of Pharmacokinetics and Pharmacodynamics in the Development of Therapeutic Proteins Mordenti Joyce, Green D. James Plenum Press
6 Conference Proceedings Physiological and Pathophysiological Alterationsi n Rat Hepatic Cytochrome P450 Schenkman B. J., Thummel E. K., Favreau V. L. Plenum Press	12 Conference Proceedings (494a) Robust Parameter Estimation for Physiologically Based Pharmacokinetics Model with Drug Dissolution Dynamics Dae Shik Kim, Jong Hwan Sung, Jong Min Lee American Institute of Chemical Engineers

1

2

3

4

5

6

7

8

9

10

11

12